Frontlight ResearchEarly access
Trial site
Clearview Cancer Institute
- 14running trials
- 7closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Lung cancer10 trials
- Prostate cancer3 trials
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Head and neck cancer1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Neuroendocrine tumours1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 311 trials
- Phase 24 trials
- Phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting11 trials
- Completed7 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- National Cancer Institute (NCI)2 trials
- Pfizer2 trials
- Astellas Pharma Global Development, Inc.1 trial
- AstraZeneca1 trial
- and 13 more
Running trials
Recruiting
Recruiting
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Prostate cancer3 recruiting
- Head and neck cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
- Neuroendocrine tumours1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026